COMPOSITION : EACH 1ML CONTAINS : CAGIRSEMA 10 MG BAC WATER FOR RECONSTITUTION
CagriSema is an investigational combination of cagrilintide, an amylin analogue, and semaglutide, a GLP-1 receptor agonist. Cagrilintide acts on amylin-related pathways involved in appetite and feelings of fullness, while semaglutide activates GLP-1 receptors, which are involved in appetite regulation and blood glucose control.
It is being investigated for weight management, appetite regulation and metabolic and blood glucose-related outcomes. Potential adverse effects associated with these drug pathways include nausea, vomiting, diarrhoea, constipation, abdominal discomfort and reduced appetite. It does not have a universal approved dosage for routine use, and its exact formulation, regulatory status, safety and appropriate dosage must be verified before any clinical claims are made.
PRESENTATION : 1 GLASS VIAL = 10MG
Made in Germany
Manufactured by Genlabs